Mary Miller

Insider Reports History

Location
Watertown, MA
Signature
/s/ Adam D. Levy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary Miller:

Company Role Class Num Shares Value Price $ Report Date Ownership
Butterfly Network, Inc. General Counsel & Corp Sec Common Stock 139,068 $749,577 $5.39 16 Feb 2022 Direct
Butterfly Network, Inc. General Counsel & Corp Sec Class A Common Stock 383,512 $391,182 $1.02 22 Mar 2022 Direct
Acrivon Therapeutics, Inc. Chief Legal Officer Common Stock 33,896 $67,114 $1.98 17 Jan 2026 Direct
Acrivon Therapeutics, Inc. Chief Legal Officer Stock Option (Right to Buy) 15,616 01 Apr 2025 Direct

Insider Reports Filed by Mary Miller

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRV Acrivon Therapeutics, Inc. 17 Jan 2026 1 -$1,305 4 Chief Legal Officer 21 Jan 2026, 16:02
ACRV Acrivon Therapeutics, Inc. 14 Nov 2025 1 -$412 4 Chief Legal Officer 18 Nov 2025, 16:32
ACRV Acrivon Therapeutics, Inc. 17 Oct 2025 1 -$1,010 4 Chief Legal Officer 21 Oct 2025, 16:06
ACRV Acrivon Therapeutics, Inc. 01 Oct 2025 1 -$514 4 Chief Legal Officer 03 Oct 2025, 16:26
ACRV Acrivon Therapeutics, Inc. 14 Aug 2025 1 -$256 4 Chief Legal Officer 18 Aug 2025, 17:18
ACRV Acrivon Therapeutics, Inc. 17 Jul 2025 1 -$737 4 Chief Legal Officer 21 Jul 2025, 16:28
ACRV Acrivon Therapeutics, Inc. 14 May 2025 1 -$210 4 Chief Legal Officer 16 May 2025, 16:20
ACRV Acrivon Therapeutics, Inc. 17 Apr 2025 1 -$1,010 4 Chief Legal Officer 18 Apr 2025, 15:51
ACRV Acrivon Therapeutics, Inc. 01 Apr 2025 1 $0 4 Chief Legal Officer 03 Apr 2025, 16:32
ACRV Acrivon Therapeutics, Inc. 01 Mar 2025 1 $0 4 Chief Legal Officer 04 Mar 2025, 17:31
ACRV Acrivon Therapeutics, Inc. 14 Feb 2025 1 -$1,176 4 Chief Legal Officer 19 Feb 2025, 16:59
ACRV Acrivon Therapeutics, Inc. 17 Jan 2025 1 -$3,809 4 Chief Legal Officer 22 Jan 2025, 16:15
ACRV Acrivon Therapeutics, Inc. 14 Nov 2024 1 -$1,457 4 Chief Legal Officer 18 Nov 2024, 16:31
ACRV Acrivon Therapeutics, Inc. 17 Oct 2024 1 -$4,391 4 Chief Legal Officer 21 Oct 2024, 16:22
ACRV Acrivon Therapeutics, Inc. 01 Oct 2024 1 -$1,982 4 Chief Legal Officer 03 Oct 2024, 18:49
ACRV Acrivon Therapeutics, Inc. 14 Aug 2024 1 -$1,292 4 Chief Legal Officer 16 Aug 2024, 16:52
ACRV Acrivon Therapeutics, Inc. 17 Jul 2024 1 -$4,291 4 Chief Legal Officer 19 Jul 2024, 16:20
ACRV Acrivon Therapeutics, Inc. 14 May 2024 1 -$1,538 4 Chief Legal Officer 16 May 2024, 19:03
ACRV Acrivon Therapeutics, Inc. 17 Apr 2024 1 -$5,770 4 Chief Legal Officer 19 Apr 2024, 16:10
ACRV Acrivon Therapeutics, Inc. 01 Mar 2024 1 $0 4 Chief Legal Officer 27 Nov 2024, 18:11
ACRV Acrivon Therapeutics, Inc. 14 Feb 2024 1 -$738 4 Chief Legal Officer 16 Feb 2024, 17:14
ACRV Acrivon Therapeutics, Inc. 17 Jan 2024 1 -$2,836 4 Chief Legal Officer 19 Jan 2024, 16:24
ACRV Acrivon Therapeutics, Inc. 14 Nov 2023 1 -$3,734 4 Chief Legal Officer 16 Nov 2023, 19:43
ACRV Acrivon Therapeutics, Inc. 17 Oct 2023 1 -$12,231 4 Chief Legal Officer 19 Oct 2023, 19:45
ACRV Acrivon Therapeutics, Inc. 26 Sep 2023 2 $0 4 Chief Legal Officer 28 Sep 2023, 20:17
ACRV Acrivon Therapeutics, Inc. 26 Sep 2023 0 $0 3 Chief Legal Officer 28 Sep 2023, 20:13
BFLY Butterfly Network, Inc. 22 Mar 2022 1 $0 4 General Counsel & Corp Sec 24 Mar 2022, 17:12
BFLY Butterfly Network, Inc. 04 Mar 2022 1 $0 4 General Counsel & Corp Sec 08 Mar 2022, 15:59
BFLY Butterfly Network, Inc. 16 Feb 2022 1 -$99,253 4 General Counsel & Corp Sec 17 Feb 2022, 16:21